Comparison of anti-spike IgG, anti-spike IgA levels and neutralizing antibody activity induced by CoronaVac and BNT162b2 vaccines in patients with inflammatory rheumatic diseases receiving immunosuppressive therapy

Table 7 Results of multiple regression analysis for predicting neutralizing antibodies with independent variables

Model	Variables	Univariable					Multivariable
Model	Variables	B	Std. Error	Standart (B)	t	p	B	Std. Error	Standart (B)	t	p
1	IS-CoronaVac	-24.806	4.800	-0.374	-5.168	*0.001^*	-22.484	4.852	-0.339	-4.634	*0.001^*
	HC-CoronaVac	-29.160	6.543	-0.329	-4.456	*0.001^*	-29.205	6.169	-0.329	-4.734	*0.001^*
	HC-BNT162b2	26.675	3.990	0.463	6.686	*0.001^*	13.987	4.291	0.243	3.26	*0.001^*
	Age	11.349	3.178	0.269	3.571	*0.001^*	3.227	3.335	0.076	0.968	0.335
	Presence of IMID	-16.552	4.150	-0.297	-.3988	*0.001^*	9.643	6.211	0.167	1.553	0.122

(IS Immunosuppressive group, HC Healthy controls, IMID Immune-mediated inflammatory diseases)
^**p < 0.01
^*p < 0.05

ISSN: 2520-1026